Literature DB >> 33752701

Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.

Kevin Clayton1, Jean Christophe Delpech1, Shawn Herron1, Naotoshi Iwahara1, Maria Ericsson2, Takashi Saito3,4, Takaomi C Saido4, Seiko Ikezu1, Tsuneya Ikezu5,6,7.   

Abstract

BACKGROUND: Recent studies suggest that microglia contribute to tau pathology progression in Alzheimer's disease. Amyloid plaque accumulation transforms microglia, the primary innate immune cells in the brain, into neurodegenerative microglia (MGnD), which exhibit enhanced phagocytosis of plaques, apoptotic neurons and dystrophic neurites containing aggregated and phosphorylated tau (p-tau). It remains unclear how microglia promote disease progression while actively phagocytosing pathological proteins, therefore ameliorating pathology.
METHODS: Adeno-associated virus expressing P301L tau mutant (AAV-P301L-tau) was stereotaxically injected into the medial entorhinal cortex (MEC) in C57BL/6 (WT) and humanized APP mutant knock-in homozygote (AppNL-G-F) mice at 5 months of age. Mice were fed either chow containing a colony stimulating factor-1 receptor inhibitor (PLX5622) or control chow from 4 to 6 months of age to test the effect of microglia depletion. Animals were tested at 6 months of age for immunofluorescence, biochemistry, and FACS of microglia. In order to monitor microglial extracellular vesicle secretion in vivo, a novel lentiviral EV reporter system was engineered to express mEmerald-CD9 (mE-CD9) specifically in microglia, which was injected into the same region of MEC.
RESULTS: Expressing P301L tau mutant in the MEC induced tau propagation to the granule cell layer of the hippocampal dentate gyrus, which was significantly exacerbated in AppNL-G-F mice compared to WT control mice. Administration of PLX5622 depleted nearly all microglia in mouse brains and dramatically reduced propagation of p-tau in WT and to a greater extent in AppNL-G-F mice, although it increased plaque burden and plaque-associated p-tau+ dystrophic neurites. Plaque-associated MGnD microglia strongly expressed an EV marker, tumor susceptibility gene 101, indicative of heightened synthesis of EVs. Intracortical injection of mE-CD9 lentivirus successfully induced microglia-specific expression of mE-CD9+ EV particles, which were significantly enhanced in Mac2+ MGnD microglia compared to Mac2- homeostatic microglia. Finally, consecutive intracortical injection of mE-CD9 lentivirus and AAV-P301L-tau into AppNL-G-F mice revealed encapsulation of p-tau in microglia-specific mE-CD9+ EVs as determined by super-resolution microscopy and immuno-electron microscopy. DISCUSSION: Our findings suggest that MGnD microglia hyper-secrete p-tau+ EVs while compacting Aβ plaques and clearing NP tau, which we propose as a novel mechanistic link between amyloid plaque deposition and exacerbation of tau propagation in AppNL-G-F mice.

Entities:  

Keywords:  Adeno-associated virus; Alzheimer’s disease; Amyloid precursor protein; Amyloid-beta peptide; Extracellular vesicles; Humanized mouse model; Lentivirus; Microglia; Microtubule-associated protein tau; Neuritic plaque; Tauopathy

Mesh:

Substances:

Year:  2021        PMID: 33752701      PMCID: PMC7986521          DOI: 10.1186/s13024-021-00440-9

Source DB:  PubMed          Journal:  Mol Neurodegener        ISSN: 1750-1326            Impact factor:   14.195


  49 in total

1.  Synaptic pruning by microglia is necessary for normal brain development.

Authors:  Rosa C Paolicelli; Giulia Bolasco; Francesca Pagani; Laura Maggi; Maria Scianni; Patrizia Panzanelli; Maurizio Giustetto; Tiago Alves Ferreira; Eva Guiducci; Laura Dumas; Davide Ragozzino; Cornelius T Gross
Journal:  Science       Date:  2011-07-21       Impact factor: 47.728

2.  Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

Authors:  Zhuohao He; Jing L Guo; Jennifer D McBride; Sneha Narasimhan; Hyesung Kim; Lakshmi Changolkar; Bin Zhang; Ronald J Gathagan; Cuiyong Yue; Christopher Dengler; Anna Stieber; Magdalena Nitla; Douglas A Coulter; Ted Abel; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

3.  Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.

Authors:  Augusta Pisanu; Daniela Lecca; Giovanna Mulas; Jadwiga Wardas; Gabriella Simbula; Saturnino Spiga; Anna R Carta
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

4.  Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

Authors:  Jessica Koenigsknecht; Gary Landreth
Journal:  J Neurosci       Date:  2004-11-03       Impact factor: 6.167

Review 5.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases.

Authors:  Joshua A Smith; Arabinda Das; Swapan K Ray; Naren L Banik
Journal:  Brain Res Bull       Date:  2011-10-18       Impact factor: 4.077

6.  A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Authors:  David E Hurtado; Laura Molina-Porcel; Michiyo Iba; Awo K Aboagye; Steven M Paul; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

Review 7.  Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration.

Authors:  Aleksandra Deczkowska; Hadas Keren-Shaul; Assaf Weiner; Marco Colonna; Michal Schwartz; Ido Amit
Journal:  Cell       Date:  2018-05-17       Impact factor: 41.582

Review 8.  Microglia in infectious diseases of the central nervous system.

Authors:  Monica M Mariani; Tammy Kielian
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-02       Impact factor: 4.147

Review 9.  Phagocytosis of microglia in the central nervous system diseases.

Authors:  Ruying Fu; Qingyu Shen; Pengfei Xu; Jin Jun Luo; Yamei Tang
Journal:  Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.590

Review 10.  Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy.

Authors:  Kevin A Clayton; Alicia A Van Enoo; Tsuneya Ikezu
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

View more
  30 in total

1.  Correction to: Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.

Authors:  Kevin Clayton; Jean Christophe Delpech; Shawn Herron; Naotoshi Iwahara; Maria Ericsson; Takashi Saito; Takaomi C Saido; Seiko Ikezu; Tsuneya Ikezu
Journal:  Mol Neurodegener       Date:  2021-04-14       Impact factor: 14.195

Review 2.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

3.  Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.

Authors:  Yong Yang; Tamaki Ishima; Xiayun Wan; Yan Wei; Lijia Chang; Jiancheng Zhang; Youge Qu; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-04       Impact factor: 5.270

4.  Inflammatory Pathways Are Impaired in Alzheimer Disease and Differentially Associated With Apolipoprotein E Status.

Authors:  Courtney M Kloske; Adam J Dugan; Erica M Weekman; Zachary Winder; Ela Patel; Peter T Nelson; David W Fardo; Donna M Wilcock
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-26       Impact factor: 3.148

5.  Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.

Authors:  Lige Leng; Ziqi Yuan; Ruiyuan Pan; Xiao Su; Han Wang; Jin Xue; Kai Zhuang; Ju Gao; Zhenlei Chen; Hui Lin; Wenting Xie; Huifang Li; Zhenyi Chen; Keke Ren; Xiao Zhang; Wenting Wang; Zi-Bing Jin; Shengxi Wu; Xinglong Wang; Zengqiang Yuan; Huaxi Xu; Hei-Man Chow; Jie Zhang
Journal:  Nat Metab       Date:  2022-10-06

Review 6.  Microglia: Friend and foe in tauopathy.

Authors:  Kristian F Odfalk; Kevin F Bieniek; Sarah C Hopp
Journal:  Prog Neurobiol       Date:  2022-06-14       Impact factor: 10.885

Review 7.  The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.

Authors:  Katja Badanjak; Sonja Fixemer; Semra Smajić; Alexander Skupin; Anne Grünewald
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.

Authors:  Diana P Benitez; Shenyi Jiang; Jack Wood; Rui Wang; Chloe M Hall; Carlijn Peerboom; Natalie Wong; Katie M Stringer; Karina S Vitanova; Victoria C Smith; Dhaval Joshi; Takashi Saito; Takaomi C Saido; John Hardy; Jörg Hanrieder; Bart De Strooper; Dervis A Salih; Takshashila Tripathi; Frances A Edwards; Damian M Cummings
Journal:  Mol Neurodegener       Date:  2021-07-15       Impact factor: 14.195

Review 9.  Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.

Authors:  Aiko Robert; Michael Schöll; Thomas Vogels
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 10.  Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading.

Authors:  Inês Dinis Aires; Teresa Ribeiro-Rodrigues; Raquel Boia; Magda Ferreira-Rodrigues; Henrique Girão; António Francisco Ambrósio; Ana Raquel Santiago
Journal:  Biomolecules       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.